These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 29948916)

  • 1. Extended release delivery system of metoprolol succinate using hot-melt extrusion: effect of release modifier on methacrylic acid copolymer.
    Sawant KP; Fule R; Maniruzzaman M; Amin PD
    Drug Deliv Transl Res; 2018 Dec; 8(6):1679-1693. PubMed ID: 29948916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of lidocaine forms (salt vs. freebase) on properties of drug-eudragit® L100-55 extrudates prepared by reactive melt extrusion.
    Liu X; Ma X; Kun E; Guo X; Yu Z; Zhang F
    Int J Pharm; 2018 Aug; 547(1-2):291-302. PubMed ID: 29883791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of plasticizer level on the drug release from sustained release film coated and hot-melt extruded dosage forms.
    Zhu Y; Mehta KA; McGinity JW
    Pharm Dev Technol; 2006; 11(3):285-94. PubMed ID: 16895839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of melt extruded enteric matrix pellets.
    Schilling SU; Shah NH; Waseem Malick A; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release floating multiparticulates of metoprolol succinate by hot melt extrusion.
    Malode VN; Paradkar A; Devarajan PV
    Int J Pharm; 2015 Aug; 491(1-2):345-51. PubMed ID: 26142246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters.
    Riekes MK; Dereymaker A; Berben P; Augustijns P; Stulzer HK; Van den Mooter G
    Int J Pharm; 2017 Mar; 520(1-2):49-58. PubMed ID: 28153650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of 3D-printed dual-release fixed-dose combination through double-melt extrusion.
    Oh HS; Park JB
    Int J Pharm; 2024 Aug; 661():124407. PubMed ID: 38955239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-polymer intermolecular interactions in hot-melt extruded solid dispersions.
    Maniruzzaman M; Morgan DJ; Mendham AP; Pang J; Snowden MJ; Douroumis D
    Int J Pharm; 2013 Feb; 443(1-2):199-208. PubMed ID: 23262428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers.
    Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
    Drug Dev Ind Pharm; 2006 Jun; 32(5):569-83. PubMed ID: 16720412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of plasticiser type on the hot melt extrusion of venlafaxine hydrochloride.
    Bounartzi M; Panagopoulou A; Kantiranis N; Malamataris S; Nikolakakis I
    J Pharm Pharmacol; 2014 Feb; 66(2):297-308. PubMed ID: 24433428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Particle Size and Drug Load on Amorphous Solid Dispersions Containing pH-Dependent Soluble Polymers and the Weak Base Ketoconazole.
    Monschke M; Kayser K; Wagner KG
    AAPS PharmSciTech; 2021 Jan; 22(1):44. PubMed ID: 33438107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DEVELOPMENT AND EVALUATION OF IVABRADINE HCI-LOADED POLYMERIC MICROSPHERES PREPARED WITH EUDRAGIT L100-55 (METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER) AND ETHYL CELLULOSE FOR CONTROLLED DRUG RELEASE.
    Majeed A; Ranjha NM; Hanif M; Abbas G; Khan MA
    Acta Pol Pharm; 2017 Mar; 74(2):565-578. PubMed ID: 29624261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained-Release Solid Dispersion of High-Melting-Point and Insoluble Resveratrol Prepared through Hot Melt Extrusion to Improve Its Solubility and Bioavailability.
    Zhu W; Fan W; Zhang X; Gao M
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in-vitro-in-vivo taste assessment of bitter drug: comparative electronic tongues study.
    Maniruzzaman M; Douroumis D
    J Pharm Pharmacol; 2015 Jan; 67(1):43-55. PubMed ID: 25182780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of Curcumin-Eudragit
    Fan W; Zhang X; Zhu W; Zhang X; Di L
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding.
    Claeys B; Vervaeck A; Hillewaere XK; Possemiers S; Hansen L; De Beer T; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2015 Feb; 90():44-52. PubMed ID: 25448075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation.
    Sarode AL; Sandhu H; Shah N; Malick W; Zia H
    Eur J Pharm Sci; 2013 Feb; 48(3):371-84. PubMed ID: 23267847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Controlled Release Polymer-Lipid Formulations Processed by Hot Melt Extrusion.
    Maniruzzaman M; Islam MT; Halsey S; Amin D; Douroumis D
    AAPS PharmSciTech; 2016 Feb; 17(1):191-9. PubMed ID: 26689407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.